AMGN Stock Analysis: Buy, Sell, or Hold?
AMGN - Amgen Inc
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 7, 2026 at $410.94 · last confirmed Aug 14, 2026
Get Alerted When AMGN Hits Your Target Price
Join 10,000+ traders who never miss a move
Interactive Price Chart (1 Month)
Loading historical data...
📊 MIXED SIGNALS: AMGN shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.3x Exit PE.
In-depth Analysis How we analyze
Technical Outlook: Technically, AMGN is in a strong uptrend. The price is approaching resistance at $421.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AMGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Protect Your Profits
AMGN is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($381.59)
- NEUTRAL: Market pricing in 3.9% annual earnings growth - fairly valued
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
Support & Resistance Levels
Fundamental Context
Data refreshes hourly during market hours. Next update: 3:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Is AMGN showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1297 | 41 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$274 | 66 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 44 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$235 | 55 HOLD |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$137 | 46 HOLD |
Advanced AMGN Option Strategies
Professional options setups generated by AI based on today's AMGN price and gamma walls.
